SI-BONE, Inc. (SIBN)
USD 13.71
(-4.53%)
USD 13.71
(-4.53%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 156.35 Million USD | 4.02% |
| 2022 | 150.31 Million USD | 14.4% |
| 2021 | 131.39 Million USD | 27.5% |
| 2020 | 103.05 Million USD | 6.77% |
| 2019 | 96.51 Million USD | 54.39% |
| 2018 | 62.51 Million USD | 3.8% |
| 2017 | 60.22 Million USD | 10.5% |
| 2016 | 54.5 Million USD | -12.37% |
| 2015 | 62.19 Million USD | 3.95% |
| 2014 | 59.83 Million USD | 19.91% |
| 2013 | 49.9 Million USD | 11.76% |
| 2012 | 44.65 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 41.9 Million USD | 1.76% |
| 2024 Q2 | 41.65 Million USD | -0.61% |
| 2023 Q2 | 38.95 Million USD | 2.29% |
| 2023 Q1 | 38.07 Million USD | -0.21% |
| 2023 Q4 | 41.18 Million USD | 7.97% |
| 2023 FY | 156.35 Million USD | 4.02% |
| 2023 Q3 | 38.14 Million USD | -2.07% |
| 2022 Q2 | 40 Million USD | 10.12% |
| 2022 Q3 | 35.83 Million USD | -10.43% |
| 2022 Q4 | 38.15 Million USD | 6.5% |
| 2022 FY | 150.31 Million USD | 14.4% |
| 2022 Q1 | 36.32 Million USD | 1.51% |
| 2021 Q4 | 35.78 Million USD | 8.42% |
| 2021 Q3 | 33 Million USD | 0.68% |
| 2021 Q1 | 29.81 Million USD | 7.49% |
| 2021 FY | 131.39 Million USD | 27.5% |
| 2021 Q2 | 32.78 Million USD | 9.95% |
| 2020 Q4 | 27.74 Million USD | 4.8% |
| 2020 Q3 | 26.47 Million USD | 19.93% |
| 2020 FY | 103.05 Million USD | 6.77% |
| 2020 Q1 | 26.77 Million USD | 1.98% |
| 2020 Q2 | 22.07 Million USD | -17.56% |
| 2019 Q4 | 26.25 Million USD | 4.44% |
| 2019 Q3 | 25.13 Million USD | 9.91% |
| 2019 Q2 | 22.86 Million USD | 2.71% |
| 2019 FY | 96.51 Million USD | 54.39% |
| 2019 Q1 | 22.26 Million USD | 20.03% |
| 2018 Q2 | 14.17 Million USD | -2.76% |
| 2018 Q3 | 15.2 Million USD | 7.24% |
| 2018 Q4 | 18.54 Million USD | 22.0% |
| 2018 FY | 62.51 Million USD | 3.8% |
| 2018 Q1 | 14.58 Million USD | 2.74% |
| 2017 Q4 | 14.19 Million USD | -7.81% |
| 2017 Q1 | 15.66 Million USD | 0.0% |
| 2017 FY | 60.22 Million USD | 10.5% |
| 2017 Q2 | 14.9 Million USD | -4.91% |
| 2017 Q3 | 15.39 Million USD | 3.32% |
| 2016 Q1 | 14.27 Million USD | 0.0% |
| 2016 FY | 54.5 Million USD | -12.37% |
| 2015 Q1 | 15.8 Million USD | -3.78% |
| 2015 FY | 62.19 Million USD | 3.95% |
| 2014 Q1 | 12.78 Million USD | 0.0% |
| 2014 FY | 59.83 Million USD | 19.91% |
| 2014 Q4 | 16.42 Million USD | 0.0% |
| 2013 FY | 49.9 Million USD | 11.76% |
| 2012 FY | 44.65 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1293.006% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -176.346% |
| Bioventus Inc. | 409.91 Million USD | 61.858% |
| BrainsWay Ltd. | 28.01 Million USD | -458.038% |
| Cerus Corporation | 143.15 Million USD | -9.218% |
| Envoy Medical, Inc. | 17.89 Million USD | -773.567% |
| electroCore, Inc. | 32.03 Million USD | -388.124% |
| IceCure Medical Ltd | 16.87 Million USD | -826.47% |
| OrthoPediatrics Corp. | 137.01 Million USD | -14.109% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -268.474% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -786.694% |
| MaxCyte, Inc. | 84.84 Million USD | -84.278% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2604.4% |
| PAVmed Inc | 64.82 Million USD | -141.182% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1276.224% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -206.102% |
| RxSight, Inc. | 103.85 Million USD | -50.555% |
| Sight Sciences, Inc. | 126.44 Million USD | -23.647% |
| TELA Bio, Inc. | 84.18 Million USD | -85.719% |
| Talis Biomedical Corporation | 67.18 Million USD | -132.714% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -123.18% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 23.118% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -526.758% |
| Inogen, Inc. | 236.08 Million USD | 33.773% |
| Spectral AI, Inc. | 20.86 Million USD | -649.382% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -179.213% |
| CVRx, Inc. | 76.14 Million USD | -105.341% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -4331.723% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1151.91% |
| Orthofix Medical Inc. | 667.42 Million USD | 76.574% |
| Venus Concept Inc. | 80.47 Million USD | -94.283% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1159.7% |
| LivaNova PLC | 843.54 Million USD | 81.465% |
| 908 Devices Inc. | 68.08 Million USD | -129.658% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 67.669% |
| Nemaura Medical Inc. | 7.13 Million USD | -2090.157% |
| NeuroPace, Inc. | 75.29 Million USD | -107.648% |
| LENSAR, Inc. | 33.33 Million USD | -369.015% |
| Apyx Medical Corporation | 51.01 Million USD | -206.462% |
| Cutera, Inc. | 197.72 Million USD | 20.925% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -530.931% |
| BioSig Technologies, Inc. | 28.53 Million USD | -448.023% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 18.344% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -333.586% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 81.306% |
| Axonics, Inc. | 270.2 Million USD | 42.136% |
| Outset Medical, Inc. | 198.77 Million USD | 21.341% |
| IRIDEX Corporation | 31.81 Million USD | -391.453% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 13.244% |
| IRadimed Corporation | 30.12 Million USD | -419.045% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1732.525% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1890.897% |
| Telesis Bio, Inc. | 63.48 Million USD | -146.265% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -58.808% |
| Varex Imaging Corporation | 224.8 Million USD | 30.449% |
| Quipt Home Medical Corp. | 148.66 Million USD | -5.169% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1233.712% |
| Pulmonx Corporation | 112.68 Million USD | -38.748% |
| Dynatronics Corporation | 9.9 Million USD | -1478.024% |
| Modular Medical, Inc. | 17.52 Million USD | -791.956% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -674.513% |
| Semler Scientific, Inc. | 38.94 Million USD | -301.476% |
| InMode Ltd. | 215.68 Million USD | 27.508% |
| Bruker Corporation | 1.07 Billion USD | 85.475% |
| Cytosorbents Corporation | 48.33 Million USD | -223.461% |
| DexCom, Inc. | 1.69 Billion USD | 90.755% |
| Align Technology, Inc. | 2.07 Billion USD | 92.472% |
| Viveve Medical, Inc. | 22.17 Million USD | -605.141% |
| ZimVie Inc. | 275.12 Million USD | 43.171% |
| Movano Inc. | 29.69 Million USD | -426.612% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -13.9% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2604.4% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -4331.723% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 73.981% |
| Profound Medical Corp. | 33.6 Million USD | -365.287% |
| Insulet Corporation | 939.9 Million USD | 83.365% |
| enVVeno Medical Corporation | 25.23 Million USD | -519.506% |
| Surmodics, Inc. | 98.69 Million USD | -58.415% |
| iCAD, Inc. | 22.22 Million USD | -603.492% |
| Nuwellis, Inc. | 22.61 Million USD | -591.421% |
| Biotricity, Inc. | 17.18 Million USD | -809.835% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 64.935% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1173.475% |
| InspireMD, Inc. | 22.95 Million USD | -581.268% |
| PAVmed Inc. | 64.82 Million USD | -141.182% |
| BIOLASE, Inc. | 34.66 Million USD | -351.086% |
| Beyond Air, Inc. | 61.7 Million USD | -153.405% |
| FONAR Corporation | 28.6 Million USD | -446.592% |
| AxoGen, Inc. | 149.33 Million USD | -4.697% |
| Vivani Medical, Inc. | 26.96 Million USD | -479.829% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 11.712% |
| Inari Medical, Inc. | 448.59 Million USD | 65.147% |
| UFP Technologies, Inc. | 58.08 Million USD | -169.158% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -3072.965% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2374.578% |
| Tenon Medical, Inc. | 16.96 Million USD | -821.446% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2014.852% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -254.515% |
| AdaptHealth Corp. | 1.07 Billion USD | 85.496% |
| Sintx Technologies, Inc. | 15.2 Million USD | -928.557% |
| NanoVibronix, Inc. | 4.97 Million USD | -3043.998% |
| Quanterix Corporation | 118.1 Million USD | -32.389% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1233.712% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -982.613% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 60.182% |
| TransMedics Group, Inc. | 182.82 Million USD | 14.478% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -457.103% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1308.703% |
| Hyperfine, Inc. | 52.87 Million USD | -195.716% |
| Establishment Labs Holdings Inc. | 172 Million USD | 9.1% |
| Biomerica, Inc. | 6.97 Million USD | -2140.628% |
| Bone Biologics Corporation | 9.42 Million USD | -1558.315% |
| AVITA Medical, Inc. | 80.77 Million USD | -93.553% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1416.32% |
| Silk Road Medical, Inc | 186.35 Million USD | 16.101% |